If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

CTKB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,254,368.41

Cytek Biosciences Insider Trading History Chart

Cytek Biosciences Share Price & Price History

^$8.44

▼ -0.31 (-3.54%)

As of 03/24/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Cytek Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/24/2023	Patrik Jeanmonod	CFO	Sell	3,000	$8.33	$24,990.00	111,201
3/20/2023	Ming Yan	CTO	Sell	20,000	$9.29	$185,800.00	7,906,053
3/7/2023	Wenbin Jiang	CEO	Sell	20,000	$10.13	$202,600.00	7,704,439
2/21/2023	Ming Yan	CTO	Sell	20,000	$10.94	$218,800.00	7,926,053
2/8/2023	Ming Yan	CTO	Sell	897	$13.53	$12,136.41	7,944,844
2/7/2023	Wenbin Jiang	CEO	Sell	20,000	$13.19	$263,800.00	7,720,314
2/3/2023	Ming Yan	CTO	Sell	1,092	$13.50	$14,742.00	7,945,741
1/24/2023	Patrik Jeanmonod	CFO	Sell	3,500	$11.05	$38,675.00	76,132
1/19/2023	Ming Yan	CTO	Sell	20,000	$11.03	$220,600.00	7,946,833
1/9/2023	Wenbin Jiang	CEO	Sell	20,000	$10.66	$213,200.00	7,740,314
12/27/2022	Patrik Jeanmonod	CFO	Sell	3,500	$9.77	$34,195.00	79,632
12/19/2022	Ming Yan	CTO	Sell	20,000	$10.38	$207,600.00	7,966,833
12/7/2022	Wenbin Jiang	CEO	Sell	20,000	$11.86	$237,200.00	7,760,314
11/25/2022	Patrik Jeanmonod	CFO	Sell	3,500	$14.30	$50,050.00	83,132
11/21/2022	Ming Yan	CTO	Sell	20,000	$14.66	$293,200.00	7,986,833
11/14/2022	Jack Ball	Director	Sell	16,000	$14.69	$235,040.00	3,000
11/7/2022	Wenbin Jiang	CEO	Sell	20,000	$14.76	$295,200.00	7,785,820
10/24/2022	Patrik Jeanmonod	CFO	Sell	3,500	$15.16	$53,060.00	85,563
10/19/2022	Ming Yan	CTO	Sell	20,000	$14.42	$288,400.00	8,005,624
10/7/2022	Wenbin Jiang	CEO	Sell	20,000	$14.79	$295,800.00	7,805,820
9/26/2022	Patrik Jeanmonod	CFO	Sell	3,500	$12.63	$44,205.00	89,063
9/19/2022	Ming Yan	CTO	Sell	20,000	$12.42	$248,400.00	8,025,624
9/7/2022	Wenbin Jiang	CEO	Sell	20,000	$12.89	$257,800.00	7,825,820
8/24/2022	Patrik Jeanmonod	CFO	Sell	3,500	$13.45	$47,075.00	92,563
8/19/2022	Ming Yan	CTO	Sell	20,000	$13.62	$272,400.00	8,045,624
8/8/2022	Wenbin Jiang	CEO	Sell	20,000	$15.09	$301,800.00	7,841,541
8/1/2022	Patrik Jeanmonod	CFO	Sell	3,500	$12.80	$44,800.00	94,994
7/19/2022	Ming Yan	CTO	Sell	20,000	$11.83	$236,600.00	8,064,415
7/7/2022	Wenbin Jiang	CEO	Sell	20,000	$11.19	$223,800.00	7,861,541
6/21/2022	Ming Yan	CTO	Sell	20,000	$10.06	$201,200.00	8,084,415
6/7/2022	Wenbin Jiang	CEO	Sell	20,000	$10.75	$215,000.00	7,881,541
5/19/2022	Ming Yan	CTO	Sell	20,000	$9.92	$198,400.00	8,104,415
5/9/2022	Wenbin Jiang	CEO	Sell	20,000	$8.01	$160,200.00	7,896,040
4/19/2022	Ming Yan	CTO	Sell	20,000	$10.34	$206,800.00	8,122,803
4/7/2022	Wenbin Jiang	CEO	Sell	20,000	$10.54	$210,800.00	7,916,040
3/21/2022	Ming Yan	CTO	Sell	20,000	$11.64	$232,800.00
3/14/2022	Ra Capital Management, L.P.	Director	Buy	342,143	$12.35	$4,225,466.05
3/11/2022	Ra Capital Management, L.P.	Director	Buy	337,492	$12.77	$4,309,772.84
3/9/2022	Ra Capital Management, L.P.	Director	Buy	40,154	$12.99	$521,600.46
3/7/2022	Ra Capital Management, L.P.	Director	Buy	337,901	$12.61	$4,260,931.61
3/7/2022	Wenbin Jiang	CEO	Sell	20,000	$12.65	$253,000.00
3/4/2022	Ra Capital Management, L.P.	Director	Buy	63,662	$12.99	$826,969.38
3/2/2022	Ra Capital Management, L.P.	Director	Buy	138,255	$12.89	$1,782,106.95
2/28/2022	Ra Capital Management, L.P.	Director	Buy	8,746	$12.97	$113,435.62
2/24/2022	Ra Capital Management, L.P.	Director	Buy	186,467	$13.03	$2,429,665.01
2/22/2022	Ming Yan	CTO	Sell	20,000	$13.44	$268,800.00
2/22/2022	Ra Capital Management, L.P.	Director	Buy	214,922	$13.46	$2,892,850.12
2/18/2022	Ra Capital Management, L.P.	Director	Buy	166,229	$14.12	$2,347,153.48
2/16/2022	Ra Capital Management, L.P.	Director	Buy	166,200	$14.98	$2,489,676.00
2/14/2022	Ra Capital Management, L.P.	Director	Buy	166,229	$14.72	$2,446,890.88
2/10/2022	Ming Yan	CTO	Sell	20,000	$15.11	$302,200.00
2/7/2022	Wenbin Jiang	CEO	Sell	20,000	$14.40	$288,000.00

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Cytek Biosciences (NASDAQ:CTKB)

49.48% of Cytek Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cytek Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2023	Voya Investment Management LLC	160,353	$1.64M	0.0%	+21.7%	0.119%
2/21/2023	Macquarie Group Ltd.	1,052,736	$10.75M	0.0%	N/A	0.781%
2/16/2023	Point72 Middle East FZE	12,552	$0.13M	0.0%	N/A	0.009%
2/15/2023	Squarepoint Ops LLC	85,433	$0.87M	0.0%	N/A	0.063%
2/15/2023	Millennium Management LLC	134,730	$1.38M	0.0%	-67.0%	0.100%
2/15/2023	Morgan Stanley	189,585	$1.94M	0.0%	-11.8%	0.141%
2/15/2023	Algert Global LLC	73,313	$0.75M	0.0%	+59.2%	0.054%
2/14/2023	Point72 Asset Management L.P.	812,662	$8.30M	0.0%	+20.7%	0.603%
2/14/2023	Price T Rowe Associates Inc. MD	19,976	$0.20M	0.0%	+8.5%	0.015%
2/14/2023	Miura Global Management LLC	780,000	$7.96M	4.0%	-4.9%	0.578%
2/14/2023	Parkwood LLC	39,904	$0.41M	0.1%	-5.7%	0.030%
2/14/2023	Pura Vida Investments LLC	420,749	$4.30M	0.2%	-20.2%	0.312%
2/14/2023	Engineers Gate Manager LP	32,796	$0.34M	0.0%	N/A	0.024%
2/13/2023	Charles Schwab Investment Management Inc.	668,061	$6.82M	0.0%	+2.0%	0.495%
2/13/2023	Deutsche Bank AG	56,457	$0.58M	0.0%	+9.3%	0.042%
2/13/2023	Barclays PLC	30,659	$0.31M	0.0%	+533.3%	0.023%
2/13/2023	Renaissance Technologies LLC	391,800	$4M	0.0%	+84.9%	0.291%
2/13/2023	Credit Suisse AG	54,373	$0.56M	0.0%	+15.4%	0.040%
2/13/2023	Geode Capital Management LLC	1,786,135	$18.24M	0.0%	+3.2%	1.325%
2/13/2023	JPMorgan Chase & Co.	68,275	$0.70M	0.0%	+7.9%	0.051%
2/13/2023	Teacher Retirement System of Texas	13,114	$0.13M	0.0%	-37.6%	0.010%
2/10/2023	Bank of America Corp DE	552,552	$5.64M	0.0%	-33.3%	0.410%
2/10/2023	Aigen Investment Management LP	14,102	$0.14M	0.0%	N/A	0.010%
2/10/2023	Lord Abbett & CO. LLC	477,166	$4.87M	0.0%	N/A	0.354%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	49,053	$0.50M	0.0%	+3.1%	0.036%
2/9/2023	First Trust Advisors LP	207,067	$2.11M	0.0%	N/A	0.154%
2/9/2023	Principal Financial Group Inc.	47,646	$0.49M	0.0%	+3.6%	0.035%
2/9/2023	Citigroup Inc.	2,518	$26K	0.0%	-28.0%	0.002%
2/8/2023	UBS Group AG	45,116	$0.46M	0.0%	+1,024.2%	0.033%
2/8/2023	Swiss National Bank	162,600	$1.66M	0.0%	+2.8%	0.121%
2/8/2023	Arizona State Retirement System	18,994	$0.19M	0.0%	+4.1%	0.014%
2/7/2023	State Board of Administration of Florida Retirement System	19,120	$0.20M	0.0%	+17.2%	0.014%
2/7/2023	Fox Run Management L.L.C.	19,881	$0.20M	0.1%	N/A	0.015%
2/2/2023	SG Americas Securities LLC	128,754	$1.32M	0.0%	+526.7%	0.095%
2/2/2023	ProShare Advisors LLC	14,693	$0.15M	0.0%	+16.7%	0.011%
2/1/2023	NorthCrest Asset Manangement LLC	52,050	$0.53M	0.0%	N/A	0.039%
1/30/2023	New York State Common Retirement Fund	827,123	$8.45M	0.0%	+30.7%	0.613%
1/30/2023	Versor Investments LP	17,400	$0.18M	0.0%	N/A	0.013%
1/26/2023	Strs Ohio	40,100	$0.41M	0.0%	+84.8%	0.030%
12/8/2022	Bank of New York Mellon Corp	394,034	$5.80M	0.0%	+20.1%	0.292%
11/21/2022	California State Teachers Retirement System	102,882	$1.51M	0.0%	-3.5%	0.076%
11/16/2022	Advisory Research Inc.	41,750	$0.61M	0.1%	N/A	0.031%
11/15/2022	State Street Corp	2,030,253	$29.89M	0.0%	+17.6%	1.506%
11/15/2022	Algert Global LLC	46,055	$0.68M	0.0%	+116.5%	0.034%
11/15/2022	UBS Asset Management Americas Inc.	69,822	$1.03M	0.0%	+9.2%	0.052%
11/15/2022	Vanguard Group Inc.	7,687,505	$113.16M	0.0%	+22.5%	5.701%
11/15/2022	Perceptive Advisors LLC	1,289,534	$18.98M	0.6%	N/A	0.956%
11/15/2022	Price T Rowe Associates Inc. MD	18,403	$0.27M	0.0%	+68.9%	0.014%
11/15/2022	Pura Vida Investments LLC	527,164	$7.76M	0.4%	+10.5%	0.391%
11/15/2022	Quantamental Technologies LLC	10,040	$0.15M	0.1%	N/A	0.007%
11/15/2022	Ensign Peak Advisors Inc	7,210	$0.11M	0.0%	N/A	0.005%
11/15/2022	Bank of New York Mellon Corp	394,034	$5.80M	0.0%	+20.1%	0.292%
11/15/2022	BlackRock Inc.	7,917,642	$116.55M	0.0%	+10.9%	5.871%
11/14/2022	Royal Bank of Canada	2,074	$30K	0.0%	+222.0%	0.002%
11/14/2022	Point72 Asset Management L.P.	673,487	$9.91M	0.0%	-56.2%	0.499%
11/14/2022	Cubist Systematic Strategies LLC	44,366	$0.65M	0.0%	-47.3%	0.033%
11/14/2022	PDT Partners LLC	31,436	$0.46M	0.1%	-31.9%	0.023%
11/14/2022	Renaissance Technologies LLC	211,900	$3.12M	0.0%	+30.1%	0.157%
11/14/2022	Lazard Asset Management LLC	2,305	$33K	0.0%	-64.8%	0.002%
11/14/2022	Nuveen Asset Management LLC	1,339,924	$19.72M	0.0%	+201.4%	0.994%
11/10/2022	Credit Suisse AG	47,115	$0.69M	0.0%	+3.5%	0.035%
11/10/2022	Hillsdale Investment Management Inc.	344,529	$5.07M	0.5%	N/A	0.256%
11/10/2022	Tower Research Capital LLC TRC	8,244	$0.12M	0.0%	+114.1%	0.006%
11/10/2022	UBS Group AG	4,013	$59K	0.0%	+6,269.8%	0.003%
11/8/2022	New York State Common Retirement Fund	633,007	$9.32M	0.0%	+785.5%	0.470%
11/3/2022	Teacher Retirement System of Texas	21,004	$0.31M	0.0%	+98.1%	0.016%
11/3/2022	The Manufacturers Life Insurance Company	45,542	$0.67M	0.0%	-1.5%	0.034%
11/3/2022	Barclays PLC	4,841	$71K	0.0%	-72.6%	0.004%
10/31/2022	SG Americas Securities LLC	20,545	$0.30M	0.0%	-33.3%	0.015%
10/27/2022	Strs Ohio	21,700	$0.32M	0.0%	N/A	0.016%
10/26/2022	Allspring Global Investments Holdings LLC	5,077	$74K	0.0%	+54.4%	0.004%
8/22/2022	Legal & General Group Plc	39,654	$0.43M	0.0%	+302.5%	0.029%
8/18/2022	Goldman Sachs Group Inc.	74,892	$0.80M	0.0%	-88.5%	0.056%
8/16/2022	Jane Street Group LLC	20,239	$0.22M	0.0%	-73.9%	0.015%
8/16/2022	Price T Rowe Associates Inc. MD	10,895	$0.12M	0.0%	N/A	0.008%
8/16/2022	Pura Vida Investments LLC	477,164	$5.12M	0.3%	+12.4%	0.354%
8/16/2022	Parkwood LLC	42,292	$42K	0.1%	+44.3%	0.031%
8/15/2022	State Street Corp	1,725,820	$18.52M	0.0%	+30.7%	1.285%
8/15/2022	PDT Partners LLC	46,168	$0.50M	0.0%	+137.6%	0.034%
8/15/2022	Cubist Systematic Strategies LLC	84,124	$0.90M	0.0%	-64.3%	0.063%
8/15/2022	Point72 Asset Management L.P.	1,536,079	$16.48M	0.1%	+143.4%	1.144%
8/15/2022	Citadel Advisors LLC	264,928	$2.84M	0.0%	+945.1%	0.197%
8/15/2022	Millennium Management LLC	902,482	$9.68M	0.0%	+666.3%	0.672%
8/15/2022	UBS Asset Management Americas Inc.	63,957	$0.69M	0.0%	N/A	0.048%
8/13/2022	Teacher Retirement System of Texas	10,603	$0.11M	0.0%	N/A	0.008%
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	8,967	$96K	0.0%	N/A	0.007%
8/13/2022	Renaissance Technologies LLC	162,900	$1.75M	0.0%	+200.0%	0.121%
8/13/2022	American International Group Inc.	53,444	$0.57M	0.0%	+10.3%	0.040%
8/12/2022	Northern Trust Corp	828,616	$8.89M	0.0%	+17.1%	0.617%
8/12/2022	Credit Suisse AG	45,511	$0.49M	0.0%	N/A	0.034%
8/12/2022	FMR LLC	520,845	$5.59M	0.0%	+0.5%	0.388%
8/12/2022	Glenview Capital Management LLC	500,000	$5.37M	0.1%	+802.3%	0.372%
8/12/2022	Rhumbline Advisers	128,967	$1.38M	0.0%	+34.0%	0.096%
8/11/2022	Trexquant Investment LP	74,678	$0.80M	0.0%	+34.3%	0.056%
8/11/2022	JPMorgan Chase & Co.	61,454	$0.66M	0.0%	+23.1%	0.046%
8/10/2022	Principal Financial Group Inc.	98,400	$1.06M	0.0%	+519.3%	0.073%
8/9/2022	Swiss National Bank	158,100	$1.70M	0.0%	N/A	0.118%
8/9/2022	Lazard Asset Management LLC	6,555	$70K	0.0%	N/A	0.005%
8/5/2022	State Board of Administration of Florida Retirement System	16,320	$0.18M	0.0%	N/A	0.012%
8/1/2022	ProShare Advisors LLC	12,827	$0.14M	0.0%	-29.9%	0.010%

Data available starting January 2016

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Today's Range

Now: $8.44

$8.17

$8.84

50 Day Range

MA: $10.98

$8.44

$13.47

52 Week Range

Now: $8.44

$7.38

$16.05

Volume

762,514 shs

Average Volume

774,049 shs

Market Capitalization

$1.14 billion

P/E Ratio

422.21

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Cytek Biosciences?: Cytek Biosciences' top insider investors include:
Ming Yan (CTO)
Wenbin Jiang (CEO)
Patrik Jeanmonod (CFO)
Jack Ball (Director)
Ra Capital Management, LP (Director)
Learn More about top insider investors at Cytek Biosciences.
Who are the major institutional investors of Cytek Biosciences?: Cytek Biosciences' top institutional investors include:
Geode Capital Management LLC — 1.32%
Macquarie Group Ltd. — 0.78%
New York State Common Retirement Fund — 0.61%
Point72 Asset Management L.P. — 0.60%
Miura Global Management LLC — 0.58%
Charles Schwab Investment Management Inc. — 0.50%
Learn More about top institutional investors of Cytek Biosciences stock.
Which institutional investors are selling Cytek Biosciences stock?: Within the last quarter, CTKB stock was sold by these institutional investors:
Bank of America Corp DE
Millennium Management LLC
Pura Vida Investments LLC
Miura Global Management LLC
Morgan Stanley
Teacher Retirement System of Texas
Parkwood LLC
Citigroup Inc.
In the last year, company insiders that have sold Cytek Biosciences company stock include:
Ming Yan (CTO)
Wenbin Jiang (CEO)
Patrik Jeanmonod (CFO)
Jack Ball (Director)
Learn More investors selling Cytek Biosciences stock.
Which institutional investors are buying Cytek Biosciences stock?: During the last quarter, CTKB stock was acquired by institutional investors including:
Macquarie Group Ltd.
Lord Abbett & CO. LLC
First Trust Advisors LP
New York State Common Retirement Fund
Renaissance Technologies LLC
Point72 Asset Management L.P.
SG Americas Securities LLC
Squarepoint Ops LLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

CTKB Insider Trading

Cytek Biosciences Insider Trading History Chart

Cytek Biosciences Share Price & Price History

Cytek Biosciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for Cytek Biosciences (NASDAQ:CTKB)

Institutional Buying and Selling by Quarter

Cytek Biosciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Cytek Biosciences?

Who are the major institutional investors of Cytek Biosciences?

Which institutional investors are selling Cytek Biosciences stock?

Which institutional investors are buying Cytek Biosciences stock?